WXXWY

WuXi Biologics (Cayman) Inc. [WXXWY] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

WXXWY Stock Summary

Top 10 Correlated ETFs

WXXWY

Top 10 Correlated Stocks

WXXWY

In the News

WXXWY Financial details

Company Rating
-
Market Cap
7.35B
Income
8.23B
Revenue
29.64B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
12.4K
Optionable
No
Shortable
Yes
Earnings
26 Mar 2024
P/E
22.53
Forward P/E
-
PEG
1.71
P/S
6.65
P/B
2.84
P/C
-
P/FCF
-311
Quick Ratio
0.94
Current Ratio
1.98
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.88
EPS next Y
-
EPS next Q
-
EPS this Y
30.86%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
45.96%
Revenue last 5Y
43.21%
Revenue Q/Q
5.33%
EPS Q/Q
20.93%
-
-
-
-
SMA20
-16.25%
SMA50
12.03%
SMA100
29.2%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
13%
ROC
0.15%
Gross Margin
44%
Oper. Margin
40%
Profit Margin
29%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.26-13.84
52W High
-58.23%
52W Low
+81%
RSI
44.81
Rel Volume
0.15
Avg Volume
301.38K
Volume
45.8K
Perf Week
-14.08%
Perf Month
-4.23%
Perf Quarter
28.37%
Perf Half Y
23.41%
-
-
-
-
Beta
0.663
-
-
Volatility
0.5%, 0.81%
Prev Close
5.23%
Price
5.43
Change
6.89%

Something similar

Top by Market Cap
TL0.DE
JPM
1YD.DE
BRH.DE
VTSAX
Top Correlated ETFs
EMHD.L
MLPA
COM
144600.KS
HDEM.L
Top Correlated Stocks
YUMC
GTE
GTE.TO
VALE
E
Similar Market Cap
SFM
000544.SZ
0HEJ.L
SPTS
600835.SS

Company Profile

Healthcare Biotechnology
  • Volume Average 301.38K
  • Market Capitalization 7.35B
  • Employee 12.4K
  • CEO Dr. Zhisheng Chen
  • Headquarters Wuxi,CN
  • IPO Date 2017-12-18
  • Website https://www.wuxibiologics.com

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.